计算溶液所需的质量、体积或浓度。
ANX005 (anti-C1q) (Ab177901) - SEC
The purity of ANX005 (anti-C1q) (Ab177901) is more than 95% verified by HPLC.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab177901-100μg |
100μg |
现货 ![]() |
| |
| Ab177901-1mg |
1mg |
现货 ![]() |
| |
| Ab177901-5mg |
5mg |
现货 ![]() |
| |
| Ab177901-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | ANX005 (anti-C1q) |
|---|---|
| 别名 | C1qa antibody | C1QA_HUMAN antibody | C1QB antibody | C1QC antibody | Complement C1q subcomponent subunit A antibody | Complement C1q subcomponent subunit B antibody | Complement C1q subcomponent subunit C antibody | Complement component 1 q subcomponent |
| 英文别名 | C1qa antibody | C1QA_HUMAN antibody | C1QB antibody | C1QC antibody | Complement C1q subcomponent subunit A antibody | Complement C1q subcomponent subunit B antibody | Complement C1q subcomponent subunit C antibody | Complement component 1 q subcomponent |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | C1QA |
| 种属反应性 | 人(Human),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 27.3 kDa (Light Chain) & 55.1 kDa (Heavy Chain), under reducing conditions; 193.6 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 抗体 |
ANX005 (anti-C1q) (Ab177901) - SEC
The purity of ANX005 (anti-C1q) (Ab177901) is more than 95% verified by HPLC.
ANX005 (anti-C1q) (Ab177901) - ELISA
Immobilized Human C1Q Protein at 2.0 μg/mL can bind ANX005 (anti-C1q) (Ab177901) with the EC₅₀ of 21.11 ng/mL.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-03-08 | Ab177901 | |
| 分析证书 | 24-03-08 | Ab177901 | |
| 分析证书 | 24-03-08 | Ab177901 |
| 1. and Reid, K B KB.. (1979) Complete amino acid sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement.. The Biochemical journal, (1): [PMID:486087] |
| 2. Sellar, G C GC, Blake, D J DJ and Reid, K B KB.. (1991) Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q.. The Biochemical journal, (1): [PMID:1706597] |
| 3. Reid, K B KB, Gagnon, J J and Frampton, J J.. (1982) Completion of the amino acid sequences of the A and B chains of subcomponent C1q of the first component of human complement.. The Biochemical journal, (1): [PMID:6981411] |
| 4. and Petry, F F.. (1998) Molecular basis of hereditary C1q deficiency.. Immunobiology, [PMID:9777412] |
| 5. Gaboriaud, Christine C and 8 more authors.. (2003) The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.. The Journal of biological chemistry, (21): [PMID:12960167] |
| 6. Wang, Yaning Y, Fei, David D, Vanderlaan, Martin M and Song, An A.. (2004) Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro.. Angiogenesis, [PMID:15886877] |
| 7. Kang, Mingsong M and 6 more authors.. (2013) Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway.. The Journal of biological chemistry, (12): [PMID:23720782] |
| 8. Son, Myoungsun M and 5 more authors.. (2017) Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression.. Scientific reports, (21): [PMID:28325905] |
| 9. Deveuve, Quentin; Lajoie, Laurie; Barrault, Benjamin and Thibault, Gilles.. (2020) The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.. Frontiers in immunology, [PMID:32117299] |